Increased risk of hepatotoxicity and hyperuricemia in elderly Taiwanese multidrug-resistant tuberculosis patients taking pyrazinamide

Código QR

Increased risk of hepatotoxicity and hyperuricemia in elderly Taiwanese multidrug-resistant tuberculosis patients taking pyrazinamide

Guardado en:

Detalles Bibliográficos
Autores principales:	D. Truong, G. Peng, L.C. Chien, A. Lin
Formato:	article
Lenguaje:	EN
Publicado:	Ubiquity Press 2016
Materias:	Infectious and parasitic diseases RC109-216 Public aspects of medicine RA1-1270
Acceso en línea:	https://doaj.org/article/ab1fbda7c670412bba180150653fcbae
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Trends of comorbidities in taiwanese patients infected with multi-drug resistant tuberculosis in seeking favorable treatment outcomes
por: S. Cheng, et al.
Publicado: (2016)

PYRAZINAMIDE/PYRAZINOIC ACID RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS: RECENT FINDINGS AND IMPLICATIONS FOR IMPROVING THE TREATMENT OF TUBERCULOSIS
por: R. M. Anthony, et al.
Publicado: (2018)

GENETIC DIVERSITY OF MULTIDRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS ISOLATES IN PAKISTAN
por: Z. Bakuła, et al.
Publicado: (2018)

Immunological detection of pyrazine-2-carboxylic acid for the detection of pyrazinamide resistance in Mycobacterium tuberculosis.
por: Edgar A Florentini, et al.
Publicado: (2020)

Correction: Immunological detection of pyrazine-2-carboxylic acid for the detection of pyrazinamide resistance in Mycobacterium tuberculosis.
por: Edgar A Florentini, et al.
Publicado: (2021)

Correction: Immunological detection of pyrazine-2-carboxylic acid for the detection of pyrazinamide resistance in Mycobacterium tuberculosis
por: Edgar A. Florentini, et al.
Publicado: (2021)

Intracellular localisation of Mycobacterium tuberculosis affects efficacy of the antibiotic pyrazinamide
por: Pierre Santucci, et al.
Publicado: (2021)

The molecular basis of pyrazinamide activity on Mycobacterium tuberculosis PanD
por: Qingan Sun, et al.
Publicado: (2020)

LOOKING INSIDE THE FOREST: FROM CLASSICAL GENOTYPING OF MYCOBACTERIUM TUBERCULOSIS TO WHOLE GENOME SEQUENCING IN HIGH MULTIDRUG RESISTANCE SETTINGS
por: J. Perdigão
Publicado: (2018)

GENOTYPING OF MULTIDRUG AND PREEXTENSIVELY DRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS ISOLATES FROM A HIGH INCIDENCE TB AREA IN MOROCCO
por: I. Chaoui, et al.
Publicado: (2018)

Genetic Diversity and Transmission of Multidrug-Resistant Mycobacterium tuberculosis strains in Lusaka, Zambia
por: Joseph Yamweka Chizimu, et al.
Publicado: (2022)

Increasing prevalence of resistance to second-line drugs among multidrug-resistant Mycobacterium tuberculosis isolates in Kuwait
por: Noura M. Al-Mutairi, et al.
Publicado: (2021)

Molecular epidemiology of multidrug resistant tuberculosis in Mongolia and Eastern Siberia: two independent dissemination processes for dominant strains
por: S. N. Zhdanova, et al.
Publicado: (2021)

Interaction of Alcohol Consumption and <i>ABCG2</i> rs2231142 Variant Contributes to Hyperuricemia in a Taiwanese Population
por: I-Chieh Chen, et al.
Publicado: (2021)

Risk factors for mortality and multidrug resistance in pulmonary tuberculosis in Guatemala: A retrospective analysis of mandatory reporting
por: Kevin Montes, et al.
Publicado: (2021)

WHOLE GENOME SEQUENCING SHEDS LIGHT ON THE TRANSMISSION DYNAMICS OF A MULTIDRUG RESISTANT MYCOBACTERIUM TUBERCULOSIS OUTBREAK OVER 23 YEARS IN A HIGH INCIDENCE SETTING
por: A. Dippenaar, et al.
Publicado: (2018)

A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide
por: Adam N. Yadon, et al.
Publicado: (2017)

<named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> Pyrazinamide Resistance Determinants: a Multicenter Study
por: Paolo Miotto, et al.
Publicado: (2014)

Epidemiological analysis of factors influencing the course of multidrug-resistant tuberculosis in HIV-infected patients with concomitant viral hepatitis
por: A. V. Kukurika, et al.
Publicado: (2021)

Hyperuricemia is associated with metabolic syndrome in the community very elderly in Chengdu
por: Gang Huang, et al.
Publicado: (2020)

A Multinational Analysis of Mutations and Heterogeneity in PZase, RpsA, and PanD Associated with Pyrazinamide Resistance in M/XDR Mycobacterium tuberculosis
por: S. M. Ramirez-Busby, et al.
Publicado: (2017)

High rate of successful treatment outcomes among childhood rifampicin/multidrug-resistant tuberculosis in Pakistan: a multicentre retrospective observational analysis
por: Farah Naz, et al.
Publicado: (2021)

The clinical outcomes of oldest old patients with tuberculosis treated by regimens containing rifampicin, isoniazid, and pyrazinamide
por: Lin HS, et al.
Publicado: (2016)

DEVELOPMENT OF FUNCTIONAL NANOSTRUCTURES EFFECTIVE AGAINST BACTERIA BIOFILMS INCLUDING MULTIDRUG RESISTANT BACTERIA
por: E. I. Koshel, et al.
Publicado: (2018)

EFFECTS OF PYRAZINAMIDE ON PREGNANT ALBINO RATS
por: Pascale Quintino,Marisa, et al.
Publicado: (2003)

Contribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosis.
por: Diana Machado, et al.
Publicado: (2012)

Diabetes mellitus and the risk of multidrug resistant tuberculosis: a meta-analysis
por: Qianqian Liu, et al.
Publicado: (2017)

EVOLUTION AND TRANSMISSION OF MYCOBACTERIUM TUBERCULOSIS RESISTANCE TO FLUOROQUINOLONES
por: T. Luo
Publicado: (2018)

ANALYSIS OF SECONDARY RESISTANCE OF MYCOBACTERIUM TUBERCULOSIS TO SECOND-LINE ANTI-TUBERCULOSIS DRUGS IN CASABLANCA
por: G. Momen, et al.
Publicado: (2018)

IDENTIFICATION OF MUTATIONS OF RESISTANCE TO FLUOROQUINOLONES, AMINOGLYCOSIDES AND ETHAMBUTOL IN RIFAMPICIN-RESISTANT MYCOBACTERIUM TUBERCULOSIS
por: I. V. Bakshtanovskaya, et al.
Publicado: (2018)

Pyrazinamide triggers degradation of its target aspartate decarboxylase
por: Pooja Gopal, et al.
Publicado: (2020)

High prevalence of primary multidrug resistant tuberculosis in persons with no known risk factors.
por: Larissa Otero, et al.
Publicado: (2011)

Genomic Analysis of Multidrug-Resistant Mycobacterium tuberculosis Strains From Patients in Kazakhstan
por: Asset Daniyarov, et al.
Publicado: (2021)

WGS IN ROUTINE DIAGNOSTICS OF TUBERCULOSIS — PREDICTION OF DRUG RESISTANCE AND GENOTYPING
por: H. Soini
Publicado: (2018)

Distribution patterns of drug resistance Mycobacterium tuberculosis among HIV negative and positive tuberculosis patients in Western Kenya
por: Martin O. Ogwang, et al.
Publicado: (2021)

Anti-Tuberculosis Drug Induced Hepatotoxicity and Associated Factors among Tuberculosis Patients at Selected Hospitals, Ethiopia
por: Molla Y, et al.
Publicado: (2021)

Association Between Low Serum Testosterone and the Development of Metabolic Syndrome in Elderly Taiwanese Men
por: Zhong SR, et al.
Publicado: (2021)

PRIMARY MULTIDRUG RESISTANCE OF TUBERCULOSIS MYCOBACTERIUM ACCORDING TO DATA OF KRASNOYARSK REGIONAL TUBERCULOSIS DISPENSARY № 1 IN-PATIENT DEPARTMENT
por: N. M. Koretskaya, et al.
Publicado: (2012)

Pyrazinamide and derivatives block ethylene biosynthesis by inhibiting ACC oxidase
por: Xiangzhong Sun, et al.
Publicado: (2017)

THE CORRELATION BETWEEN LEVELS OF PHENOTYPIC RESISTANCE AND GENOTYPIC MUTATIONS OF M. TUBERCULOSIS
por: N. Ciobanu, et al.
Publicado: (2018)